EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Use of sensitivity analyses to assess uncontrolled confounding from unmeasured variables in observational, active comparator pharmacoepidemiologic studies: a systematic review

Chase D Latour iD, Megan Delgado iD, I-Hsuan Su iD, Catherine Wiener iD, Clement O Acheampong iD, Charles Poole, Jessie K Edwards iD, Kenneth Quinto, Til Stürmer iD, Jennifer L Lund iD, Jie Li, Nahleen Lopez und 2 weitere

American Journal of Epidemiology · 05.02.2025 · 194 (2) · 524-535

DOI: 10.1093/aje/kwae234 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift American Journal of Epidemiology, online erschienen am 03.08.2024. Verfasst von Chase D Latour und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Hauptthemen laut MEDLINE: Pharmacoepidemiology, Observational Studies as Topic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes for Health, The University of North Carolina at Chapel Hill.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the potential for, and direction and magnitude of uncontrolled confounding is critical for generating informative real-world evidence. Many sensitivity analyses are available to assess robustness of study results to residual confounding, but it is unclear how researchers are using these methods. We conducted a systematic review of published active-comparator cohort studies of drugs or biologics to summarize use of sensitivity analyses aimed at assessing uncontrolled confounding from an unmeasured variable. We reviewed articles in 5 medical and 7 epidemiologic journals published between January 1, 2017, and June 30, 2022. We identified 158 active-comparator cohort studies: 76 from medical and 82 from epidemiologic journals. Residual, unmeasured, or uncontrolled confounding was noted as a potential concern in 93% of studies, but only 84 (53%) implemented at least 1 sensitivity analysis to assess uncontrolled confounding from an unmeasured variable. The most common analyses were E-values among medical journal articles (21%) and restriction on measured variables among epidemiologic journal articles (22%). Researchers must rigorously consider the role of residual confounding in their analyses and the best sensitivity analyses for assessing this potential bias. This article is part of a Special Collection on Pharmacoepidemiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacoepidemiologyObservational Studies as TopicHumansConfounding Factors, Epidemiologic

Stichwörter der Autor:innen

active comparatorcohortconfoundingobservationalsensitivity analyses

Autor:innen und Institutionen

  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States.
  • Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States.
  • School of Medicine, Yale University, New Haven, CT, United States.

ORCID-Profile: Chase D Latour, Megan Delgado, I-Hsuan Su, Catherine Wiener, Clement O Acheampong, Jessie K Edwards, Til Stürmer, Jennifer L Lund, John Concato, Michele Jonsson Funk

Förderung

  • NIAID NIH HHS
  • National Institutes for Health
  • The University of North Carolina at Chapel Hill
  • AHRQ HHS
  • FDA HHS
  • University of North Carolina at Chapel Hill
  • National Institutes of Health
  • Food and Drug Administration

Zitieren

APA

Latour, C. D., Delgado, M., Su, I. H., Wiener, C., Acheampong, C. O., Poole, C., Edwards, J. K., Quinto, K., Stürmer, T., Lund, J. L., Li, J., Lopez, N., Concato, J., & Funk, M. J. (2025). Use of sensitivity analyses to assess uncontrolled confounding from unmeasured variables in observational, active comparator pharmacoepidemiologic studies: a systematic review. American Journal of Epidemiology, 194(2), 524-535. https://doi.org/10.1093/aje/kwae234

Vancouver

Latour CD, Delgado M, Su IH, Wiener C, Acheampong CO, Poole C, et al. Use of sensitivity analyses to assess uncontrolled confounding from unmeasured variables in observational, active comparator pharmacoepidemiologic studies: a systematic review. American Journal of Epidemiology. 2025;194(2):524-535. doi:10.1093/aje/kwae234

BibTeX
@article{Latour2025,
  author = {Latour, Chase D and Delgado, Megan and Su, I-Hsuan and Wiener, Catherine and Acheampong, Clement O and Poole, Charles and Edwards, Jessie K and Quinto, Kenneth and Stürmer, Til and Lund, Jennifer L and Li, Jie and Lopez, Nahleen and Concato, John and Funk, Michele Jonsson},
  title = {Use of sensitivity analyses to assess uncontrolled confounding from unmeasured variables in observational, active comparator pharmacoepidemiologic studies: a systematic review},
  journal = {American Journal of Epidemiology},
  year = {2025},
  volume = {194},
  number = {2},
  pages = {524--535},
  doi = {10.1093/aje/kwae234}
}
Kostenlos starten →